These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2840458)

  • 1. Feasibility and metabolic effects of a purified corn fiber food supplement.
    Earll L; Earll JM; Naujokaitis S; Pyle S; Mc Falls K; Altschul AM
    J Am Diet Assoc; 1988 Aug; 88(8):950-2. PubMed ID: 2840458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary hyperlipoproteinemia type 1].
    Yamamura T
    Nihon Rinsho; 1983 Aug; 41(8):1793-8. PubMed ID: 6632287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipoproteinemia type I].
    Bustos P; Fernández E; Radrigán E
    Rev Chil Pediatr; 1987; 58(6):481-4. PubMed ID: 3506219
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physical activity in the management of hyperlipoproteinemia].
    Lederer J
    Sem Hop; 1982 May; 58(21):1285-90. PubMed ID: 6287583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of a purified bran preparation in men with low HDL cholesterol.
    Lithell H; Selinus I; Vessby B
    Hum Nutr Clin Nutr; 1984 Jul; 38(4):309-13. PubMed ID: 6088439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alcohol and hyperlipoproteinemia].
    Reuter W
    Z Arztl Fortbild (Jena); 1983; 77(7):290-3. PubMed ID: 6858231
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 1 hyperlipoproteinaemia and pregnancy.
    Potter JM; Michael CA
    Aust N Z J Obstet Gynaecol; 1982 Aug; 22(3):155-8. PubMed ID: 6184045
    [No Abstract]   [Full Text] [Related]  

  • 14. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    Sommariva D; Scotti L; Baroni L; Beggi P; Fasoli A
    Clin Ter; 1980 Mar; 92(6):649-55. PubMed ID: 7460493
    [No Abstract]   [Full Text] [Related]  

  • 16. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipoproteinemias, diet and drug therapy. Risk of arteriosclerosis and the lipoproteins].
    Schwandt P
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):447-8. PubMed ID: 6769012
    [No Abstract]   [Full Text] [Related]  

  • 19. Conference on the Health Effects of Blood Lipids: Optimal Distributions for Populations. Workshop Report: Clinical-Pathological Section. American Health Foundation, April 11 and 12, 1979.
    Prev Med; 1979 Nov; 8(6):679-714. PubMed ID: 232270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholesterol of high density lipoproteins in the blood of women].
    Titov VN; Alamdarova IA; Kantiardzhian IG; Liakishev AA
    Lab Delo; 1983; (10):7-12. PubMed ID: 6196544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.